glp1ledger

Evidence-first, hype-free

Making sense of GLP-1 medicines, one clear answer at a time.

Semaglutide, tirzepatide, and what’s next — compared side by side, costs explained, evidence read calmly. No hype, no fear.

Our editorial standardsStart here

At a glance

SemaglutideGLP-1 · weekly
TirzepatideGIP + GLP-1 · weekly
Retatrutidein trials · not approved

Reviewed for accuracy · updated as evidence lands

First answers we’re writing

COMPARISON

Tirzepatide vs semaglutide: what the head-to-head data says

COSTS

What GLP-1s really cost in 2026 — with and without coverage

LIVING WITH IT

Keeping muscle on a GLP-1: the protein question, answered calmly

The ledger, weekly

One calm email a week: what changed, what it means, no noise.

Newsletter opens with the site.